Artha Sootra - Company Dashboard

Governance Classic Home

Hester Biosciences LtdPharmaceuticalsINE782E01017Consolidated₹2419.55+100.70 (+4.34%)

Valuation

Market Cap₹2.05K Cr

TTM PE14.96x

Forward PE12.53x

PEG0.11

Book Value₹423.47

P/B5.68x

TTM EPS₹160.95

Fwd EPS₹192.13

TTM Revenue₹325.74 Cr

TTM PAT₹136.92 Cr

TTM EBITDA₹107.56 Cr

TTM EBIT₹83.10 Cr

Last Qtr PAT₹20.63 Cr

Last Qtr EBITDA₹32.67 Cr

Last Qtr EBIT₹25.59 Cr

Profitability

ROE38.01%

ROCE29.57%

TTM NPM42.03%

TTM EBITDA %33.02%

Curr OPM122.61%

Last OPM17.05%

Curr NPM—

Last NPM—

Curr EPS₹113.71

Last EPS₹19.45

Balance sheet

Equity₹8.51 Cr

Reserve₹351.73 Cr

Total Debt₹188.25 Cr

D/E0.52x

Interest %3.18%

Curr Interest₹3.08 Cr

Price / range

Close₹2407.30

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+4.12%

1W+4.90%

1M+14.90%

3M-0.70%

6M+47.22%

1Y+50.09%

2Y+0.09%

3Y+45.13%

5Y-3.54%

Diwali+51.66%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1829.00	₹4.39L Cr	40.02	12.31%
DIVISLAB	10140.50	₹2.69L Cr	92.01	17.45%
TORNTPHARM	4710.00	₹1.59L Cr	77.30	11.42%
LAURUSLABS	2346.00	₹1.27L Cr	94.52	21.98%
ZYDUSLIFE	1193.00	₹1.20L Cr	28.65	15.39%
DRREDDY	1366.00	₹1.14L Cr	40.65	7.11%
CIPLA	1404.10	₹1.13L Cr	39.14	8.06%
MANKIND	2518.00	₹1.04L Cr	46.35	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	82.93+28.4%	72.66	93.71	70.35	64.58	292.14
Other Income	1.68	1.68	4.18	1.04	1.48	7.64
Total Income	84.60+28.1%	74.34	97.89	71.39	66.05	299.77
Interest	1.70	1.36	4.09	0.90	1.27	7.17
Expenditure	-62.26-10.8%	-54.59	-70.02	-56.75	-56.17	-237.09
PBDT	0	0	0	0	0	0
EBITDA	27.32+130.0%	24.35	31.46	16.71	11.88	72.47
Depreciation	-4.95	-4.92	-3.68	-2.21	-2.20	-10.25
EBIT	22.37+131.1%	19.43	27.78	14.50	9.68	62.22
PBT	22.34+126.1%	19.75	34.87	14.64	9.88	69.68
Tax	-5.68	-5.04	-8.49	-3.97	-2.67	-17.58
Equity	8.51	8.51	8.51	0	0	8.51
OPM	26.41	26.57	35.62	20.81	15.30	23.25
Net Profit	16.66+131.1%	14.71	26.38	10.67	7.21	52.10
NPM	19.69	19.79	26.95	15.16	11.16	17.38
EPS	19.59+131.0%	17.29	31.01	12.54	8.48	61.24

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	292.14+2.0%	286.47+0.5%	285.16+12.3%	254+15.8%	219.35+5.2%	208.48
Other Income	7.64	4.76	4.26	5.32	4.66	1.65
Total Income	299.77+2.9%	291.23+0.6%	289.42+11.6%	259.32+15.8%	224.01+6.6%	210.13
Expenditure	-237.09+5.0%	-249.47+1.3%	-252.69-17.3%	-215.40-26.1%	-170.75-13.8%	-150.06
Interest	-7.17	-5.37	-5.09	-6.50	-2.47	-3.95
PBDT	0	0	0	0	0	0
EBITDA	72.47+42.2%	50.95+7.6%	47.34-13.8%	54.89-9.4%	60.57-15.9%	72
Depreciation	-10.25	-8.58	-9.78	-9.79	-9.50	-9.63
EBIT	62.22+46.8%	42.37+12.8%	37.56-16.7%	45.10-11.7%	51.07-18.1%	62.37
PBT	69.68+66.9%	41.76+13.7%	36.73-16.4%	43.92-17.5%	53.26-2.8%	54.78
Tax	-17.58	-9.92	-9.57	-11.58	-13.74	-14.88
Equity	8.51	8.51	0	0	0	0
OPM (%)	23.25	14.34	13.00	17.00	24.00	26.00
Net Profit	52.10+63.6%	31.84+17.2%	27.16-16.0%	32.34-18.2%	39.52-1.0%	39.90
NPM (%)	17.38	10.93	9.00	12.00	18.00	19.00
EPS (Rs)	61.24+63.6%	37.43+17.2%	31.93-16.0%	38.02-18.1%	46.45-1.0%	46.90
CEPS	61.24	37.43	31.93	38.02	46.45	46.90

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	97.91+38.0%	77.24	100.11	77.42	70.97	332.60
Other Income	1.53	1.64	-3.03	0.67	9.73	9.68
Total Income	99.44+23.2%	78.89	97.08	78.08	80.70	342.28
Interest	2.99	3.08	5.10	1.82	2.21	10.93
Expenditure	-75.31-14.4%	-64.59	-76.79	-65.88	-65.81	-275.76
PBDT	0	0	0	0	0	0
EBITDA	32.67+178.8%	22.77	34.33	17.79	11.72	86.65
Depreciation	-7.08	-7.04	-5.91	-4.43	-4.35	-18.88
EBIT	25.59+247.2%	15.73	28.42	13.36	7.37	67.77
PBT	24.55+65.0%	99.65	23.23	12.21	14.88	69.46
Tax	-5.82	-4.95	-8.54	-4.21	-2.71	-18.35
Equity	8.51	8.51	8.51	0	0	8.51
OPM	24.69	126.32	23.93	15.64	18.44	20.29
Net Profit	20.63+44.0%	96.73	16.55	9.31	14.33	57.48
NPM	20.75	122.61	17.05	11.92	17.76	16.79
EPS	23.94+42.1%	113.71	19.45	10.94	16.85	67.57

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	332.60+6.9%	311.10+2.2%	304.55+14.5%	266.09+13.2%	235.01+9.6%	214.33
Other Income	9.68	3.92	10.64	15.15	13.74	4.68
Total Income	342.28+8.6%	315.030.0%	315.18+12.1%	281.24+13.1%	248.75+13.6%	219.02
Expenditure	-275.76+1.4%	-279.56+2.9%	-287.84-17.2%	-245.50-25.5%	-195.67-18.2%	-165.59
Interest	-10.93	-12.70	-19.78	-9.32	-4.06	-6.60
PBDT	0	0	0	0	0	0
EBITDA	86.65+42.0%	61.04+13.8%	53.66+6.0%	50.61-15.6%	59.98-12.6%	68.65
Depreciation	-18.88	-16.80	-17.17	-20.70	-16.58	-13.31
EBIT	67.77+53.2%	44.24+21.2%	36.49+22.0%	29.91-31.1%	43.40-21.6%	55.34
PBT	69.46+95.8%	35.47+29.7%	27.34-23.5%	35.75-32.6%	53.08+5.9%	50.10
Tax	-18.35	-10.75	-10.79	-12.12	-14.02	-15.41
Equity	8.51	8.51	0	0	0	0
OPM (%)	20.29	11.26	8.68	12.71	21.34	22.88
Net Profit	57.48+99.4%	28.83+36.2%	21.17-24.5%	28.04-29.0%	39.48+13.8%	34.70
NPM (%)	16.79	9.15	6.72	9.97	15.87	15.84
EPS (Rs)	67.57+99.4%	33.89+36.2%	24.88-24.5%	32.96-29.0%	46.41+13.8%	40.79
CEPS	67.57	33.89	24.88	0	46.41	40.79

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	11	14 Jul 2026
2025	Final Dividend	7	06 Aug 2025
2024	Final Dividend	6	22 Aug 2024
2023	Final Dividend	8	13 Sep 2023
2022	Final Dividend	10	11 Aug 2022
2021	Final Dividend	10	05 Aug 2021
2020	Final Dividend	6.6	27 Aug 2020
2019	Final Dividend	7	18 Jul 2019
2019	Interim Dividend	2	09 Nov 2018
2019	Interim Dividend	2	30 Aug 2018
2018	Final Dividend	6	02 Aug 2018
2018	Interim Dividend	4	16 Nov 2017
2017	Final Dividend	2.3	20 Jul 2017
2017	Interim Dividend	3	03 Nov 2016
2016	Final Dividend	1.1	21 Jul 2016
2016	Interim Dividend	3	17 Mar 2016
2015	Final Dividend	3.1	10 Sep 2015
2014	Final Dividend	2	18 Sep 2014
2013	Final Dividend	2	07 Aug 2013
2012	Final Dividend	1	27 Aug 2012
2011	Final Dividend	3.5	25 Aug 2011
2010	Final Dividend	3	22 Jul 2010
2009	Final Dividend	2.5	13 Aug 2009
2008	Final Dividend	2.5	21 Aug 2008

Bonus

Year	Ratio	Ex-Date
2012	1:2	27 Sep 2012

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split